Fan, J., Zhou, J., Huang, X., Gao, Q., Shi, J., He, Y., Shen, Z., Wang, W., Wei, S., Gu, L., Zheng, L., Gu, S., Zhao, Z., Xu, R., Zhang, Q., Li, B., Tang, Y., Ding, X., He, X. (2025). Phase I study of Ori-C101, an armored GPC3-directed CAR-T, in patients with advanced hepatocellular carcinoma (HCC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.4084